Expert Insights Newsletter

Photo

Meeting an Increased Demand for Laboratory Services as Healthcare Evolves

Increasing volumes, declining reimbursement and added cost pressures are just some of the challenges facing the hospital laboratory today. What strategies can laboratories pursue to meet these challenges and enhance the value they contribute to patient care and to their... Read more 

Photo

Testosterone Measurement — Standardizing Testing to Increase Accuracy

Testosterone testing is utilized to diagnose and monitor a range of disorders in men, women and children but variability and inaccuracy often compromise testing reliability. Initiatives led by the Endocrine Society and the Centers for Disease Control and Prevention (CDC)... Read more 

Photo

Pain Medication - The Role of Genetic Variation in Drug Metabolism

Despite the widespread use of pain medications in the United States, there is little understanding among both physicians and patients about the potential variability in response to drugs commonly used for pain management. Dr Leland McClure, Director of Pain Management,... Read more 

Photo

Managing Chronic Pain - A Structured Approach for More Effective Patient Care

Chronic pain affects a significant proportion of adults in the United States ' over 100 million Americans according to recent estimates.1 This is more people than are affected by heart disease, diabetes, and cancer combined, yet chronic pain management and... Read more 

Photo

Sexually Transmitted Infections (STIs): Advances in Testing Technology

Sexually Transmitted Infections (STIs) are a significant public health concern in the United States - chlamydia and gonorrhea are the two most commonly reported notifiable diseases in the country.1 Edward (Ned) Hook, M.D., Director, Division of Infectious Diseases, Department of... Read more 

Photo

Lung Cancer Testing: Why FISH for ALK Testing in NSCLC?

Last year the National Comprehensive Cancer Network (NCCN)1 and the American Society of Clinical Oncology (ASCO)2 issued recommendations for performing gene mutation testing to direct therapy for patients with non-small cell lung carcinoma (NSCLC). Dr. Aurelia Meloni-Ehrig, Chief Director, Cytogenetics,... Read more